Knygos.lt nariams
Knygos.lt nariams
- Planuojame turėti už 157 d.
/https://libri-media.knygos-static.lt/860a49c7-033a-4f6e-9676-f4c0ec7713d4/2)
- Leidėjas: Elsevier Science
- Metai: 2027
- Puslapiai: 250
- ISBN-10: 0443526354
- ISBN-13: 9780443526350
- Kalba: Anglų
Dissolvable Microneedles (Dmns) for Cancer Diagnosis and Treatment (el. knyga) (skaityta knyga) | knygos.lt
Atsiliepimai
Aprašymas
Dissolvable Microneedles (DMNS) For Cancer Diagnosis and Treatment presents a comprehensive, lab¿töclinic overview of dissolving microneedles (DMNs) for cancer diagnosis and therapy, emphasizing painless, minimally invasive delivery and localized treatment. The book details DMN materials, design, and fabrication-including AI¿enabled and 3D¿printed approaches-then advances to theranostic applications such as immunotherapy, photodynamic therapy, exosome¿loaded systems, and stimulus¿responsive platforms. Translation topics cover regulation, scale¿up, and CMC, alongside supportive strategies during chemotherapy.
Academic readers gain a structured synthesis of recent advances, practical methods, and clinical outlooks, positioning DMNs as patient¿friendly, cost¿effective tools with significant potential to revolutionize cancer care.
- Leidėjas: Elsevier Science
- Metai: 2027
- Puslapiai: 250
- ISBN-10: 0443526354
- ISBN-13: 9780443526350
- Kalba: Anglų
Dissolvable Microneedles (DMNS) For Cancer Diagnosis and Treatment presents a comprehensive, lab¿töclinic overview of dissolving microneedles (DMNs) for cancer diagnosis and therapy, emphasizing painless, minimally invasive delivery and localized treatment. The book details DMN materials, design, and fabrication-including AI¿enabled and 3D¿printed approaches-then advances to theranostic applications such as immunotherapy, photodynamic therapy, exosome¿loaded systems, and stimulus¿responsive platforms. Translation topics cover regulation, scale¿up, and CMC, alongside supportive strategies during chemotherapy.
Academic readers gain a structured synthesis of recent advances, practical methods, and clinical outlooks, positioning DMNs as patient¿friendly, cost¿effective tools with significant potential to revolutionize cancer care.
Atsiliepimai